SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAPEZZI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.767
AS - Asia 11.155
EU - Europa 8.391
SA - Sud America 2.274
Continente sconosciuto - Info sul continente non disponibili 793
AF - Africa 318
OC - Oceania 26
Totale 38.724
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.129
SG - Singapore 4.630
IT - Italia 2.486
FI - Finlandia 2.341
CN - Cina 1.812
BR - Brasile 1.736
VN - Vietnam 1.348
PL - Polonia 1.192
HK - Hong Kong 1.167
BD - Bangladesh 688
DE - Germania 499
FR - Francia 396
GB - Regno Unito 376
ID - Indonesia 365
RU - Federazione Russa 325
JP - Giappone 300
CA - Canada 254
MX - Messico 231
IN - India 205
AR - Argentina 185
NL - Olanda 158
UA - Ucraina 158
TR - Turchia 125
SE - Svezia 124
ZA - Sudafrica 123
IQ - Iraq 90
EC - Ecuador 85
CO - Colombia 83
AT - Austria 64
PK - Pakistan 59
MY - Malesia 55
VE - Venezuela 49
SA - Arabia Saudita 46
ES - Italia 44
MA - Marocco 41
CL - Cile 39
EG - Egitto 34
CH - Svizzera 32
PY - Paraguay 32
UZ - Uzbekistan 32
PH - Filippine 30
JM - Giamaica 28
TN - Tunisia 28
CR - Costa Rica 27
AE - Emirati Arabi Uniti 24
KE - Kenya 24
BO - Bolivia 23
AU - Australia 22
NP - Nepal 22
JO - Giordania 21
PE - Perù 21
BE - Belgio 20
IE - Irlanda 19
LT - Lituania 19
HN - Honduras 18
GT - Guatemala 17
UY - Uruguay 17
CZ - Repubblica Ceca 15
KZ - Kazakistan 14
PT - Portogallo 14
NI - Nicaragua 13
GR - Grecia 12
MD - Moldavia 12
AZ - Azerbaigian 11
BG - Bulgaria 11
SN - Senegal 11
SV - El Salvador 11
DZ - Algeria 10
IL - Israele 10
IR - Iran 10
LY - Libia 10
RO - Romania 10
TW - Taiwan 10
AL - Albania 9
BY - Bielorussia 9
KR - Corea 9
RS - Serbia 9
ET - Etiopia 8
LB - Libano 8
OM - Oman 8
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
TT - Trinidad e Tobago 7
HR - Croazia 6
HU - Ungheria 6
NG - Nigeria 6
PR - Porto Rico 6
PS - Palestinian Territory 6
TH - Thailandia 6
AO - Angola 5
CI - Costa d'Avorio 5
GE - Georgia 5
KW - Kuwait 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BH - Bahrain 4
CY - Cipro 4
EE - Estonia 4
GP - Guadalupe 4
MM - Myanmar 4
Totale 37.868
Salva come PNG Salva come JPEG
Città #
Singapore 2.624
Helsinki 2.245
Ashburn 1.940
San Jose 1.476
Warsaw 1.177
Hong Kong 1.152
Santa Clara 1.036
Fairfield 1.013
Beijing 730
Council Bluffs 655
Woodbridge 540
Houston 469
Wilmington 419
Ho Chi Minh City 411
Seattle 386
Cambridge 340
Chandler 336
New York 327
Princeton 309
Jakarta 290
Lauterbourg 282
Hanoi 269
Tokyo 268
Los Angeles 257
Milan 242
Dallas 213
Rome 205
Ann Arbor 190
Mexico City 152
São Paulo 149
Chicago 146
Moscow 144
San Diego 142
Munich 137
London 116
Jacksonville 114
Toronto 99
Dong Ket 93
Shanghai 93
Naples 88
Bologna 86
Nuremberg 80
Buffalo 72
Ferrara 63
Rio de Janeiro 63
Phoenix 60
Atlanta 56
Turku 56
Frankfurt am Main 54
Haiphong 53
Orem 52
Falls Church 51
Da Nang 50
Denver 50
Montreal 50
Tianjin 50
Brooklyn 49
Florence 49
Boardman 47
Palermo 44
Baghdad 43
Johannesburg 43
Stockholm 43
Brasília 41
Belo Horizonte 40
Chennai 37
Turin 37
Bari 35
Nanjing 34
Izmir 32
Quito 32
Redwood City 31
Tashkent 31
Bremen 30
Dhaka 30
San Francisco 30
Guangzhou 29
Salt Lake City 29
Manchester 28
Poplar 28
Kuala Lumpur 27
Norwalk 27
Biên Hòa 26
Hải Dương 26
San Anselmo 26
Washington 26
Miami 25
Campinas 24
Guayaquil 24
Medellín 24
Newark 24
Boston 23
Lahore 23
Las Vegas 23
Tampa 23
Bogotá 22
Figino 22
Vienna 22
Amman 21
Mountain View 21
Totale 23.571
Salva come PNG Salva come JPEG
Nome #
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 2.023
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel 944
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 871
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 490
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 432
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 262
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 249
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 230
Heart failure with preserved ejection fraction: uncertainties and dilemmas 230
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 230
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 219
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 219
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis 216
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 205
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 204
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 201
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 201
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 200
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 198
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 196
Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications 194
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 193
Gender-related risk of myocardial involvement in systemic amyloidosis 192
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 191
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 190
A targeted proteomics approach to amyloidosis typing 189
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 187
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 185
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 182
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 180
Treatment of cardiac transthyretin amyloidosis: An update 179
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 178
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 178
Well-known and novel players in endothelial dysfunction: Updates on a notch(ed) landscape 176
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 175
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 174
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 172
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 172
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 171
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 170
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 169
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 169
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 167
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management 166
'Corona' versus 'coronary' 165
The Mediterranean diet: a cultural journey 164
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 163
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 163
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 162
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 161
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 159
Cardiac amyloidosis: the great pretender 159
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 157
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 156
Risk Scores for Cardiac Implantable Electronic Device Infection: Which One to Believe In? 156
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 156
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 155
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 155
2019 CORONAVIRUS: What are the implications for cardiology? 153
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 153
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 152
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 151
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 151
The battle against COVID-19: Mortality in Italy 151
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 150
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 149
The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis 149
Dronedarone: Una reale innovazione o solo una valida seconda scelta? Come districarsi tra linee guida, agenzie regolatorie e pratica clinica quotidiana 149
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 146
The combination of chest computed tomography and standard electrocardiogram provides prognostic information and pathophysiological insights in COVID-19 pneumonia 146
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 144
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 142
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 142
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 141
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 141
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 141
One year on: The impact of COVID-19 on clinical research 141
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 140
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea 140
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 140
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 139
Transcatheter approach of concomitant mitral and tricuspid regurgitation 139
Myocarditis in COVID-19 patients: current problems 138
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 138
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) 137
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 137
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 135
Adapting to survive 135
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 134
Zero-fluoroscopy cardiac ablation: Technology is moving forward in complex procedures—A novel workflow for atrial fibrillation 134
Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes 133
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 133
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths 132
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 131
Performance of Synthetic Extracellular Volume Fraction in Different Cardiac Phenotypes From a Prospective Cohort of Patients Referred for Cardiac Magnetic Resonance 131
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 130
Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress 130
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man 130
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 129
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 126
Totale 20.433
Salva come PNG Salva come JPEG
Categoria #
all - tutte 242.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.551
Totale 243.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.755 0 0 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/20256.241 220 88 616 193 650 503 204 184 988 1.227 769 599
2025/202619.946 1.180 712 1.556 2.280 2.083 941 1.648 1.137 3.478 1.976 2.193 762
2026/20272.143 592 890 661 0 0 0 0 0 0 0 0 0
Totale 38.724